| Description | Lp-PLA2-IN-14 (Compound 19), an inhibitor of rhLp-PLA2, exhibits a potent inhibitory effect with a pIC50 value of 8.4. This compound is applicable in research pertaining to neurodegenerative disorders, including Alzheimer Disease (AD), glaucoma, age-related macular degeneration (AMD), and cardiovascular diseases such as atherosclerosis [1]. |
| Target activity | Lp-PLA2 (recombinant human):8.4 (pIC50) |
| molecular weight | 353.3 |
| Molecular formula | C16H14F3N3O3 |
| CAS | 2756855-66-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |